论文部分内容阅读
目的观察新癀片预防肝动脉栓塞化疗术(TACE)后发热的临床疗效。方法将49例病例随机分为观察组27例和对照组22例。两组均在TACE术后予常规对症处理,观察组同时口服新癀片,连续7天;观察患者发热程度和发热时间。结果观察组发热发生率为25.93%,明显低于对照组的86.36%(P<0.01);观察组发热程度较对照组轻(P<0.05),平均发热持续时间较对照组缩短(P<0.05)。结论新癀片能有效预防TACE术后发热的发生。
Objective To observe the clinical effect of Xinchuan Tablet in preventing fever after transcatheter arterial chemoembolization (TACE). Methods 49 cases were randomly divided into observation group 27 cases and control group 22 cases. Both groups were treated with conventional symptomatic treatment after TACE. The observation group was given oral tablets simultaneously for 7 consecutive days. The degree of fever and the duration of fever were observed. Results The incidence of fever in the observation group was 25.93%, which was significantly lower than that in the control group (86.36%, P <0.01). The fever in the observation group was lighter than that in the control group (P <0.05), and the mean duration of fever in the observation group was shorter than that in the control group ). Conclusion The new tablet can effectively prevent the occurrence of fever after TACE.